CombiMatrix has appointed Jeremy Jones to its board of directors, the Irvine, Calif.-based molecular diagnostics firm said this week.

Jones is currently chairman of On Assignment, a provider of professionals in the life sciences, healthcare, and technology sectors. He is also on the advisory board of MedidaMetrics. Jones was an investor in and chairman of home health service companies Byram Healthcare Centers and Lifecare Solutions until their sales in 2008 and 2011, respectively.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Related Articles

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.